REMPEX PHARMACEUTICALS, INC.
27Patents
27Active
27Granted
53Portfolio score
Filing activity: Sep 17, 2007 → Aug 2, 2019 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8680136B2 | Cyclic boronic acid ester derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 57 | Active |
| US9101638B2 | Boronic acid derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 49 | Active |
| US9132140B2 | Boronic acid derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 30 | Active |
| US9642869B2 | Boronic acid derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 24 | Active |
| US9012491B2 | Heterocyclic boronic acid ester derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 24 | Active |
| US9296763B2 | Cyclic boronic acid ester derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 23 | Active |
| US9156858B2 | Boronic acid derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 22 | Active |
| US9694025B2 | Cyclic boronic acid ester derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 18 | Active |
| US9241947B2 | Boronic acid derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 16 | Active |
| US9687497B1 | Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 16 | Active |
| US10004758B2 | Cyclic boronic acid ester derivatives and methods of making the same | Emerging Cross-Sectional Technologies | 15 | Active |
| US9963467B2 | Boronic acid derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 13 | Active |
| US9278105B2 | Tetracycline compositions | Human Necessities | 6 | Active |
| US10183034B2 | Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives | Emerging Cross-Sectional Technologies | 6 | Active |
| US10172874B2 | Pharmaceutical compositions comprising cyclic boronic acid ester derivatives | Emerging Cross-Sectional Technologies | 6 | Active |
| US9084802B2 | Tetracycline compositions | Human Necessities | 3 | Active |
| US10639318B2 | Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives | Emerging Cross-Sectional Technologies | 3 | Active |
| US8268865B2 | Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof | Chemistry; Metallurgy | 3 | Active |
| US7994225B2 | Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections | Emerging Cross-Sectional Technologies | 3 | Active |
| US10561675B2 | Cyclic boronic acid ester derivatives and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US8906868B2 | Aminoglycoside derivatives | Human Necessities | 0 | Active |
| US10385074B2 | Synthesis of boronate salts and uses thereof | Human Necessities | 0 | Active |
| US8178490B2 | Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US10669292B2 | Synthesis of boronate salts and uses thereof | Human Necessities | 0 | Active |
| US9744179B2 | Tetracycline compositions | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.